The actor, who was diagnosed with lymphoma, shared that his prognosis is good.
Actor Jeff Bridges announced on Monday that he has been diagnosed with cancer.
In an announcement on social media, the “Big Lebowski” actor didn’t mince words about the seriousness of his diagnosis.
With a nod to one of his signature characters, Bridges began his statement by writing, “As the Dude would say.. New S**T has come to light.”
“I have been diagnosed with Lymphoma,” he continued. “Although it is a serious disease, I feel fortunate that I have a great team of doctors and the prognosis is good.”
Bridges confirmed that he started treatment and he will “keep you posted on my recovery.”
The Academy Award-winning actor, 70, extended his sincerest gratitude to all those that have rallied around him, writing that he’s “profoundly grateful for the love and support from my family and friends.” He ended his statement by encouraging people to vote on Nov. 3.
“We are all in this together,” he stated.
Lymphoma is cancer of the body’s lymphatic system, which helps fight germs according to the Mayo Clinic. The organization added that treatment for the disease varies, but may involve chemotherapy, immunotherapy medications, radiation therapy, a bone marrow transplant or some combination thereof.
Endometriosis takes on average eight years to be diagnosed in the UK, a report has found.
The disorder affects one in 10 women of a reproductive age. It occurs when tissue similar to the lining of the womb grows in other parts of the body, usually the ovaries or fallopian tubes.
Each menstrual cycle, these cells break down and bleed, much like a period, except the blood has no way of leaving the body.
As well as reduced fertility, the main symptom is pain, which may be felt in the abdomen, during sex or when urinating.
Read more: Endometriosis patients ‘finally feel believed’
The vague signs mean endometriosis is often misdiagnosed as irritable bowel syndrome, a urinary tract infection or just heavy periods.
Despite the condition’s wide prevalence, a report by the All-Party Political Group has revealed endometriosis diagnosis rates have not improved in more than a decade.
More than 10,000 endometriosis patients took part in the inquiry, which was launched after BBC research found around half had experienced suicidal thoughts as a result of their pain.
The report’s authors found more than half (58%) of the women visited their GP more than 10 times before being diagnosed, while 53% went to A&E with symptoms, unaware they had endometriosis.
Most of the participants claimed their mental health, education or career had been damaged by the condition, with more than a third (35%) saying their income had been cut as a result.
Read more: Irregular periods linked to early death
One woman who knows the impact of this all too well is Helen-Marie Brewster, 28, from Hull.
“I failed most of my GCSEs because I was in bed, in crippling pain,” she told the BBC.
“I’ve lost nearly every job I’ve ever had because of my poor attendance.
“Last year I visited A&E 17 times trying to find help and pain relief for this condition, even for just a few days so I can keep going.”
Watch: Geordie Shore star in tears over ‘excruciating’ endometriosis pain
Around nine in 10 (90%) of the inquiry’s participants would have liked access to psychological support, which they were never offered.
The report’s authors therefore recommend compulsory menstrual wellbeing should be taught in schools throughout the UK. It is only compulsory in English schools.
Read more: Menopausal delay surgery has ‘no evidence’
With many of the participants claiming their medics seemed to be in the dark about endometriosis, the authors also want training for GPs, nurses and gynaecologists to be reviewed, as well as greater investment into diagnoses and treatments.
A woman with suspected endometriosis usually has her abdomen and vagina examined by a GP. She may then be referred for an ultrasound scan.
The only way to be sure of endometriosis is a test called a laparoscopy, which involves
By Steven Reinberg
FRIDAY, Oct. 16, 2020 (HealthDay News) — While men can take solace in a new government report that shows prostate cancer cases have been declining overall in the past two decades, the same analysis finds that the opposite is true for advanced prostate cancer cases.
In fact, the number of cases of cancer that had already spread from the prostate to other parts of the body doubled between 2003 and 2017, going from 4% to 8%, according to researchers from the U.S. Centers for Disease Control and Prevention.
“Understanding who gets prostate cancer and what the survival numbers are like could be important for men making prostate cancer screening decisions, providers discussing these decisions with their patients, and for informing recommendations for prostate cancer screening,” said lead researcher Dr. David Siegel, from CDC’s Division of Cancer Prevention and Control.
Why the spike in advanced prostate cancers? Dr. Anthony D’Amico, a professor of radiation oncology at Harvard Medical School in Boston, said the increase was an inevitable consequence of a 2012 recommendation from the U.S. Preventive Services Task Force against the routine use of prostate cancer screening with the prostate-specific antigen (PSA) test.
“We realized in 2012, when the U.S. Preventive Services Task Force said to stop PSA screening, we would expect that somewhere around 2018 to 2019 that cancer death rates would start to go up, and that about two to three years prior to that, around 2015 to 2016, we would expect to see distant metastases [cancer that has spread] go up because they preceded death by a couple of years,” he explained.
That’s exactly what this report found, D’Amico noted.
“That trend will continue because the reversal of the recommendation against PSA screening didn’t happen until , so it’s going to be a couple of years from now before we start to see a plateauing and eventually a decrease in distant disease,” he said. “We should have PSA brought back.”
While D’Amico said he believes that men should have their PSA level tested, whether an elevated PSA leads to further diagnosis or treatment should be based on a conversation between a man and his urologist.
“We’re diagnosing less low-risk cases now, but there’s no problem from my perspective in bringing the PSA back, so that the patients with low-risk cancer can have the discussion whether they want treatment or not, knowing what the side effects are, and the patients who need to be cured can be cured,” D’Amico said.
Men are getting more metastatic disease and dying, he said. “But because of the reversal of PSA screening, it should come back to where it was, and the only difference is now we’re smarter about who to treat and who not to treat,” D’Amico said.
The CDC study also delved into racial differences for prostate cancer survival. The researchers found that five-year survival was highest among Asian/Pacific Islanders (42%), followed by Hispanics (37%), American Indian/Alaska Natives (32%), Black men (32%), and white men